Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree. This is nice and might cause a temporary spike but market likely to shrug it off....probably a sell the news event if it hits between 3.20-3.50.
However if this is the first in a run of announcements a base in 3.20-3.40 would be fine.
Tox.
Lab completion.
Tox results.
Phase 1 initiation.
Etc.will move the market.
Not to take away what this signifies, but the ability to modify and develop a viricide has been known for sometime. Production of quantities necessary for Tox is a much better indicator of 'progress'.
The hatchet job by the hack writer barely even did what it was 'supposed' to today. They are really reaching for straws to try and get this 'sled' lower but it seems like most are aware that there are likely positive events pending soon.
More half cocked articles lacking even decent fundamental research much less criticism will do little to lower the share price. Majority of longs here are strong hands or looking to add.
Nothing has fundamentally changed to the negative.
Lab opening soon.
Tox commencing with requisite cGLP materials commencing in next several weeks.
No toxicity noted at max feasible dose.
Multiple reputable scientists, doctors, and institutions on board or working in conjunction.
There are still potential risks but none were addressed in the bottom of the barrel bilge dump released authoritatively this morning.
But hey maybe more longs took the opportunity to add. Definitely was not a sell-fest as the author and co. hoped.
That's laughable.
When's this thing getting above a quarter? This year?
Next year?
Ever again? Doubtful...but if it does it will be one final pump before the dump.
What a post!
For those inclined to to DD instead of just read a sensationalistic article with clear spin and bias.
NNVC is a great company with great product potential.
It has challenges to say the least. Some presented by its operations, but most due to outside reasons and the rigid industry protocols it must follow.
Some also just by the nature of today's investment environment.
Do your own research!
Best of luck to all new investors!
http://www.nanoviricides.com/
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201402180700BIZWIRE_USPRX____BW5756&feedID=600&press_symbol=95414
http://online.wsj.com/article/PR-CO-20140327-908238.html
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201403050700BIZWIRE_USPRX____BW5718&feedID=600&press_symbol=95414
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201402040700BIZWIRE_USPRX____BW5723&feedID=600&press_symbol=95414
http://www.sec.gov/Archives/edgar/data/1379006/000114420414009813/v367879_10q.htm
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201403120700BIZWIRE_USPRX____BW5489&feedID=600&press_symbol=95414
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201403270900BIZWIRE_USPRX____BW5432&feedID=600&press_symbol=95414
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201403240700BIZWIRE_USPRX____BW5548&feedID=600&press_symbol=95414
http://republicanrealestateagent.com/why-message-board-bashers-bash-stocks/
http://markets.on.nytimes.com/research/stocks/news/press_release.asp?docTag=201402111329BIZWIRE_USPRX____BW6500&feedID=600&press_symbol=95414
http://www.sec.gov/Archives/edgar/data/1379006/000114420414009813/v367879_10q.htm
Illuminating.
Without that kind of thoughtful commentary I might have missed the boat on NNVC
How insightful.
He does have a point. AstraZeneca is like AOL in the 90s and NNVC is like Google. An unestablished up and comer is difficult to compare to a mature company because the startup is charting new territory while the mature company carries on business as usual. The next 6-12 months will be interesting.
Mondays only a few minutes away...is this another news week? Not worried either way.
No. The company is moving ahead with plans. The company took requisite legal steps to deal with a baseless article. Other than the couple relevant releases only seen news about progression towards the marketable drug. I expect to see similar announcements in the coming weeks.
Still think that's possible?
Highly doubtful.
Calls for less than a dollar are laughable.
Whether they lease it or own it, it's the lab they'll use.
That question is based on a false premise.
NNVC's results have been verified by independent research institutions.
Some of which were posted in the intro until it was scrubbed.
Not gonna do research for you.
Source?
Nowhere close to IND remains to be seen.
I did. Question stands. Source?
Source?
That and institutions. Plenty of Joe six pack here, PhDs, catfish, multiple types of investors/traders savvy or otherwise, even some who speak with the SEC.
So we have cries of to the moon/bullshit. Pick a side and have fun!
Money to be made here but I have no reason to sell anytime soon. Plenty above water and plenty in the pipe to hold what i've got.
Interesting take bb1, but there's more than meets the eye here. I'm not really worried about shorts, naked or otherwise. Ultimately its up to management to deliver the results in the lab in the coming months.When that happens shorts will have to make their own decisions.
The SEC will require all that information from the form to be documented just the same whether the complaint regards NNVC or any other publically traded company.
Allegations of market tampering and or failure to comply with SEC regulations and securities law will result in an investigation by the SEC. This will be a use of departmental resources and require sufficient documentation.
Evidence of possible naked shorting in NNVC. SEC may find this interesting. Even if they do not, any buyers should beware of potential for a high level of volatility. Do your research. Check your emotions at the bid.
~1million shares failed to deliver before PT libel article!
I just started doing a little more DD after Leifsmith's and Diabolical Southpaw's previous posts on the Dendreon sudden price spike example (Thanks for that!).
There were ~1 million phantom shares in NNVC that failed to deliver before the PT libel article. Those non-existent shares diluted shareholders and contributed greatly to the share price drop. A small amount of shares that fail to deliver is not unusual for liquidity reasons. But this amount, strategically put up against legitimate short and long shares look like they were (and are being) used to manipulate the stock price and thwart true price discovery.
Bottom line is that NNVC has been chosen for this stock manipulation for the following reasons:
- Not because of problems with the science, management or progress
- But because the BioTechs are easier target with science-illiterate weak hands
- And because new bio-technology is a challenge to develop
- AND, because NNVC has consistently been tightly held with "hard-to-borrow" shares and what had been a low churn rate volume that could be more easily manipulated with fewer shares.
- And had an attractive market cap to extract value from.
- And all developmental (before commercialization) biotech startup companies always have some non-material (to the SP) issues that can be exploited and trumped up by manipulative interests.
Note that I AM NOT talking here about normal short and long sales which are legal. I am talking about excessive phantom (naked short) shares which are not delivered in the statutory 3 day time frame.
I have done a search and find on NNVC FTD from the SEC website and copied the results at the bottom of this post.
LINK: SEC.gov Failure to Deliver
Note in particular the 882,616 shares that failed to deliver by Jan 24 and ask yourself - would the share price have dropped as much on Jan 21 (and later) without those phantom shorts to push against the 2,848,000 that would normally have traded without the extra phantom shares. This amounts to over 31% of the volume that would have traded that day.
In total, there were around 1 million shares that failed to deliver in the month before the PT libel article setting up for that hit piece.
More subtle, but more important to price recovery were the nearly 30,000 shares (~10x to 100x greater than normal in that timeframe) that failed to deliver on Feb 28 which were supposedly "borrowed" on Feb 25. This date is key as the stock was making a steady rise to fill the gap after the PT libel article. Without those phantom shares sold at strategic points throughout the day, there would have been less than 300,000 shares sold. Over 10% of the shares sold that day were non-existent and not delivered in the 3-day statutory requirement. If you notice the candle for Feb. 25, the stock was driven down after it had rallied on the continuing trend to fill the gap. This is highly suspicious.
So the claims about loss of value appear more related to what very well may be illegal stock manipulation than any real or perceived loss of value in the company. Remember, institutional investment keeps increasing, there has been insider buying, and there has been great continuing strong support by longs here.
What does that mean for the share price going forward? I think we can count on continued price manipulation in the short term. But it will be difficult to continue to do so under the radar of the SEC Reg SHO statutes when the company begins to release expected news on Regulatory Tox testing, efficacy studies at ViroClinics, PHE and LRRI and the completion of the manufacturing plant. These announcements could begin any time, but are likely by mid summer.
If you are worried about continued price manipulation, note the SEC Reg SHO statutes have additional reporting requirements when these "Failures-to-deliver" shares run for 5 consecutive days or more. This would add more scrutiny and suspicion after the many complaints of individuals on this board to the SEC regarding what seems to be a criminal stock manipulation. This investigation is much more important than the civil action that NNVC is letting its lawyers handle while they continue to develop their life-saving technology.
Good Luck to all longs.
1st Half Jan 2014
DATE CUSIP Ticker FTD Shrs Company Share Price
20140103|630087203|NNVC| 14|NANOVIRICIDES, INC. NEW COMMON|4.95
20140107|630087203|NNVC| 414|NANOVIRICIDES, INC. NEW COMMON|4.88
20140108|630087203|NNVC| 389|NANOVIRICIDES, INC. NEW COMMON|4.96
20140109|630087203|NNVC| 200|NANOVIRICIDES, INC. NEW COMMON|4.91
20140113|630087203|NNVC| 680|NANOVIRICIDES, INC. NEW COMMON|5.01
20140114|630087203|NNVC| 98|NANOVIRICIDES, INC. NEW COMMON|5.08
2nd Half Jan 2014
20140115|630087203|NNVC| 1262|NANOVIRICIDES, INC. NEW COMMON|5.39
20140116|630087203|NNVC| 994|NANOVIRICIDES, INC. NEW COMMON|5.39
20140117|630087203|NNVC| 10264|NANOVIRICIDES, INC. NEW COMMON|5.79
20140121|630087203|NNVC| 5082|NANOVIRICIDES, INC. NEW COMMON|6.05
20140123|630087203|NNVC| 18335|NANOVIRICIDES, INC. NEW COMMON|4.84
20140124|630087203|NNVC|882616|NANOVIRICIDES, INC. NEW COMMON|4.85
20140127|630087203|NNVC| 47085|NANOVIRICIDES, INC. NEW COMMON|4.80
20140128|630087203|NNVC| 7227|NANOVIRICIDES, INC. NEW COMMON|4.85
20140129|630087203|NNVC| 5043|NANOVIRICIDES, INC. NEW COMMON|4.83
20140130|630087203|NNVC| 1592|NANOVIRICIDES, INC. NEW COMMON|4.57
20140131|630087203|NNVC| 2260|NANOVIRICIDES, INC. NEW COMMON|4.75
1st Half Feb 2014
2014 02 03 -27 |630087203|NNVC| 1680 |NANOVIRICIDES, INC. NEW COMMON| 4.58
2014 02 04 -28 |630087203|NNVC| 1674 |NANOVIRICIDES, INC. NEW COMMON| 4.42
2014 02 05 -31 |630087203|NNVC| 1305 |NANOVIRICIDES, INC. NEW COMMON| 4.65
2014 02 06 -03 |630087203|NNVC| 300 |NANOVIRICIDES, INC. NEW COMMON| 4.60
2014 02 07 -04 |630087203|NNVC| 2084 |NANOVIRICIDES, INC. NEW COMMON| 4.47
2014 02 10 -05 |630087203|NNVC| 1662 |NANOVIRICIDES, INC. NEW COMMON| 4.43
2014 02 11 -06 |630087203|NNVC| 4289 |NANOVIRICIDES, INC. NEW COMMON| 4.42
2014 02 12 -07 |630087203|NNVC| 5660 |NANOVIRICIDES, INC. NEW COMMON| 3.36
2014 02 13 -10 |630087203|NNVC| 8018 |NANOVIRICIDES, INC. NEW COMMON| 3.48
2014 02 14 -11 |630087203|NNVC| 793 |NANOVIRICIDES, INC. NEW COMMON| 3.11
2nd Half Feb 2014
17 -12 0*
2014 02 18 -13 |630087203|NNVC| 272 |NANOVIRICIDES, INC. NEW COMMON| 3.45
19 -14 0
2014 02 20 -17 |630087203|NNVC| 6989 |NANOVIRICIDES, INC. NEW COMMON| 4.00
21 -18 0
2014 02 24 -19 |630087203|NNVC| 5899 |NANOVIRICIDES, INC. NEW COMMON| 3.87
2014 02 25 -20 |630087203|NNVC| 6310 |NANOVIRICIDES, INC. NEW COMMON| 3.89
2014 02 26 -21 |630087203|NNVC| 811 |NANOVIRICIDES, INC. NEW COMMON| 3.99
27 -24 0
2014 02 28 -25 |630087203|NNVC| 29862 |NANOVIRICIDES, INC. NEW COMMON| 3.90
1st Half Mar 2014
2014 03 03 -26 |630087203|NNVC| 4834 |NANOVIRICIDES, INC. NEW COMMON| 3.98
2014 03 04 -27 |630087203|NNVC| 186 |NANOVIRICIDES, INC. NEW COMMON| 4.04
2014 03 05 -28 |630087203|NNVC| 245 |NANOVIRICIDES, INC. NEW COMMON| 3.96
06 -03 0
2014 03 07 -04 |630087203|NNVC| 172 |NANOVIRICIDES, INC. NEW COMMON| 3.79
2014 03 10 -05 |630087203|NNVC| 380 |NANOVIRICIDES, INC. NEW COMMON| 3.77
2014 03 11 -06 |630087203|NNVC| 11974 |NANOVIRICIDES, INC. NEW COMMON| 3.81
2014 03 12 -07 |630087203|NNVC| 28213 |NANOVIRICIDES, INC. NEW COMMON| 3.86
2014 03 13 -10 |630087203|NNVC| 12910 |NANOVIRICIDES, INC. NEW COMMON| 3.89
NOTE: SEC does not report days with 0 FTD. I have added the "0" days here to more clearly indicate the spike in FTD shares on Feb 28 (29,862) vs the days around it which killed the fill-the-gap rally in the shares that was well on its way after the PT libel article.
http://www.sec.gov/about/forms/formtcr.pdf
For anyone wishing to make a whistleblower complaint to the SEC regarding NNVC, here is the form.
The comparison of what's been communicated publically to what's stated in that email is splitting hairs. Reiterating already public information to the SEC will not go very far.
What is suspicious? An email discussing already known company matters?
What laws/regulations have been broken?
Useless hand-wringing.
Longs in this stock and readers here are in for the ride.
Shorts can pick the article's point(s) to articulate at opportune times.
Traders opportunity at the moment until Management delivers results. There will be forthcoming announcements that will provide temporary boosts in SP but I expect 'sell the news' until there are clinical announcements.
Pump Traders article is a long passed fart in the wind.
Still thinking of taking a position?
Just save yourself the consternation and take a position hedged with options the other way.
The back and forth must surely be tearing you up inside...if you haven't already.
And sitting on the sidelines is a position but no reason to beat yourself up about it.
When I saw that looked into dndn. That rise they experienced was incredible. But I am curious why he chose to compare NNVC to that company with scary sell-off two years after its rise.
Talk about a rollercoaster.
Then I saw the dndn piece on deep capture.
Hope NNVC is not in the sights of some of those players but it is wall st. Any things possible I guess.
Any bear raider with a brain would've closed out a position after a ride from 5 down to 1...much less .20/c. What's left to gain? Any smart money is gone. Longs are long and will either ride this out to zero or hero.No other choice.
Is this another April Fools joke dude?
You haven't gone long or short NNVC yet?
Currently this stock looks to make more for traders in the interim than a holder/long.
Whatever people state here makes only a bit of difference. Either management delivers or they don't. I still think it is possible they can. If it fundamentally changes I'll change my position.
This is the final riff of the groovy pump...dump coming just 4 or 8 beats out.
Hot shot CFOs don't work for 100k and 50k in deferred comp...this is a stinky pinky. Got it written all over it. Going to zero when the pump is over
Always a good sign when a CFO quits pending an audit. Absolutely not a red flag in an Auditor's risk assessment...
Heaven is hell in the land of true Believers.
Good luck to all.
Ran on what? Why?
People kicking dimes back and forth is fun till everything goes to hell.
Definitely gonna need a machine to pick up the mess this thing leaves when it implodes.
We'll see what happens to two dimes when those shares hit the market.
The CFO probably realizes he jumped into a shitstorm hence the notice of inability to timely file. Not really a bad thing if he's trying to accurately disclose the financials. Might even convince some of the few longs left in this dump to bail and take whatever they have left on the table before it goes out with the rest of the trash.
My cousin just called me from Buffalo. He said the lead story on this morning's news was some 'local' green energy company had come up with a way to process plastic into oil and announced the first major sale of the technology. Then I logged on and saw your Board appointment and realized what day it was....Shucks.
Bullshit.
Nice April Fool's joke Rawnoc.
Best one I got yet.
Good luck ol' chum.
A groovy new CFO?
They can inefficiently turn plastic into oil man...can't you let a dreamer dream?
Long and strong. Looking to add in this range.
Nothing has changed regarding fundamentals.
Onward and upward!
C'mon Docs on with the Tox!!!